A brief history and trend of state wise Covid-19 vaccine status in India
*Muthu Maha Laxmi
Department of Economics, St. Mary’s College (Autonomous), Thoothukudi Affiliated to Manonmaniam Sundaranar University, Abishekapatti, Tirunelveli – 627012 (India)
ABSTRACT
After the devastating second wave of COVID-19, with the rapid increase in the number of new cases in many states of India marking the beginning of a third wave of COVID-19, our best bet is taking a jab to protect against COVID-19. Currently, licensed vaccines are found to be reasonably safe and effective. The second wave of COVID-19 was devastating, but it’s a silver lining to note that most of the individuals who had taken the jab recovered with mild infections, and the hospitalization rates among jabbed individuals were meager. India is regarded as the vaccine manufacturing hub of the world, contributing 60% to the global vaccine supply. The country has the capacity to manufacture well over 3 billion coronavirus disease 2019 (COVID-19) vaccine doses annually. The ability of the country to produce low-cost COVID-19 vaccines will benefit lowincome countries that cannot afford expensive vaccines. This analysis provides an insight into the myths, pros and cons, and efficacy of the available vaccines. This paper focuses on the trend and growth of Covid- 19 vaccine doses in the Indian States and Union Territories. Secondary information was the focus of the study. The census approach is commonly employed in academic settings. The current state of Covid-19 was examined using percentage approaches, coefficients of variation, linear trends, and compound growth rates. A variety of sources, such as the Internet and books as well as newspapers and pamphlets, are utilised to gather secondary data. The data reveals that Dose1 immunisation in India was on average higher than Dose2 vaccination in India. The trend coefficient for the state-bystate vaccination status in India between October 14, 2021, and December 2, 2022, was found to be statistically significant. According to the coefficient of variance, India’s Dose1 vaccine is more reliable than Dose2 immunisation. *Assistant Professor